Drugs / Tat protein
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00751595 | Sep 2008 → Jun 2012 | HIV infectious disease | Barbara Ensoli, MD | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tat protein | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00751595 ↗ |
| Known as | HIV-1 Tat | “the biologically active HIV-1 Tat protein” PMID 25924841 ↗ Apr 2015 |
| Modality | Vaccine | “HIV-1 Tat vaccine” NCT00751595 ↗ |
| Route | Other | “by intradermal administration” NCT00751595 ↗ |